Tue, May 24, 2022

Corinne Jenkins Maintained (SWTX) at Strong Buy with Increased Target to $82 on, May 24th, 2022

Corinne Jenkins of Goldman Sachs, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Strong Buy with Increased Target from $76 to $82 on, May 24th, 2022.

Corinne, nor any peers, have made any analyst calls on SWTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30